在怀疑克罗恩氏相关并发症时,通过生物覆盖的帮助进行重复性囊袋手术:来自炎症性肠病中心的早期经验
Mehmet Gulmez1,2, Daniel J Wong2,3, Ariela K Holmer4
1Center for Advanced Inflammatory Bowel Disease Care Northwell Health Manhasset New York USA.
Annals of gastroenterological surgery
|September 9, 2025
概括
具有生物覆盖的修订性阴道囊解 (IPAA) 手术为因疑似克罗恩病 (CD) 导致囊衰竭的患者提供无门的选择. 这种方法在具有挑战性的情况下保持袋子功能的承诺.
科学领域:
- 胃肠病学和外科手术
- 炎症性肠道疾病研究研究
- 手术创新 在外科创新.
背景情况:
- 诊断的不确定性是常见的患者失败的伊利奥囊.
- 具有生物覆盖的修复性囊手术是一种替代囊切除和终结结节切除术,可用于某些疑似患有克罗恩病 (CD) 的患者.
研究的目的:
- 评估在接受修订/重置囊门解剖术 (IPAA) 的患者的术后结果,以对可能的CD.生物覆盖的失败袋进行评估.
主要方法:
- 在第三级炎性肠病中心进行了回顾性横截面研究.
- 包括在2016年9月至2022年12月期间接受修复/重复IPAA手术的患者.
- 主要结局是功能袋的速度.
主要成果:
- 17名患者接受了重复IPAA,对疑似CD的生物覆盖; 7名患者在阶段之间接受了生物药物.
- 随访时间中位数为17个月.
- 工作袋率为75%.工作袋率为75%.
结论:
- 修订IPAA手术与医学治疗相结合,为怀疑CD引起的袋子衰竭提供了无门的替代方案.
- 这种方法在具有挑战性的患者群体中保持囊功能有希望.
- 由于患者数量有限和随访变化,需要进行进一步的研究.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
456
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
456
Inflammatory Bowel Disease II: Crohn's Disease
961
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
961
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
506
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
506
Inflammatory Bowel Disease IV: Pharmacological Management
531
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
531
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
644
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
644


